Semaglutide and Tirzepatide off FDA shortage list: What does this mean for weight loss drug access?
The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.
Facing high costs and drug shortages, they turned to compounded weight loss drugs online. An FDA ban might end that.
Is the era of sourcing cheaper weight loss drugs from the internet over? High demand for GLP-1 agonists — prescription drugs ...
New Scientist on MSN21h
The Ozempic era is only just beginning
In the past year, treatments such as Wegovy, Mounjaro and Zepbound have become household names. But there are many questions ...